Today: September 28, 2016, 12:24 am

China contract research organisation market: China accounts for between 7% to 10% of global CRO market output
China Contract Research Organization (CRO) Industry Report, 2012-2013 - a new market research report on 2014-03-12 09:43:01
China´s pharmaceutical CRO market developed much later compared to the industries in Europe and the United States; 40 years later. Currently, there are 500 domestic CRO players in China with the majority of these being classed as SMEs. In 2011, the CRO market in China was valued between RMB22 and RMB28 billion although this only accounted for approximately between 7% and 10% of the total global CRO output.

There has been a race for foreign companies to start investing in China´s CRO market due to the low cost, talent resource available and rich spectrum of diseases. Mergers and acquisition activity has been strong and renowned CRO companies such as Quintiles, Covance, PPD, CRL and ICON have all recently invested in China.

The homegrown companies operating in the CRO market in China account for 14% of China´s total CRO market revenue. The leading domestic companies operating in China CRO market are WuXi AppTec Co Ltd, ShangPharma Corporation and Hangzhou Tigermed Consulting with revenues totalling US$374Mn, US$94.5Mn and US$29.84Mn, respectively.

The key domestic players of China´s CRO market have established joint ventures or alliances with foreign companies. ABO was established in 2005 following the merging of nine research institutes including Academy of Military Medical Sciences, National Institutes for Food and Drug Control and National Centre of Biomedical Analysis, the merging of three national engineering centres and also seven national engineering technology centres all with shared hi-tech resources being valued at RMB1 billion. In 2012, ABO had 38 corporate members.

In January 2013, JOINN Laboratories based in Beijing acquired the United States based R&D and production bases of Bayer which represented a new development for China´s biomedical enterprises.

The report provides detailed analysis on the international CRO market, the domestic macro-environment and policies and laws and regulations of China which is an important factor in the development of the CRO industry. Analysis is also provided on the CRO business and development dynamics in China of six foreign and five domestic industrial players.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600

# 542 Words
Related Articles
More From Finance
P2P lending platform Monexo partners with IDBI-Trusteeship [..]
For Immediate Release: 2nd September 2016 MUKESH BUBNA, CEO Monexo Fintech Pvt Limited P2P [..]
Day Trade to Win New September Class [..]
Sold Out? New Class Added – On September 6, 2016, is launching a brand new eight-week trading boot camp [..]
FTM (Forget The Market) Reopens 3 Shares [..]
Port Vila, Vanuatu, 28th July 2016 - Investment firm FTM today announced the reopening of three separate share options, projected [..]
Ex-Citibanker Launching Online P2P marketplace in India [..]
A study conducted by World Bank shows that MSMEs in India face an estimated credit gap of INR 20.9 trillion [..]
New Frontier Portfolios Top Morningstar Rankings
New Frontier’s global strategic portfolios topped the Global Balanced Strategic/All-Inclusive category of the latest Morningstar ETF [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.